Oct 12 (Reuters) - S2Medical AB (publ) S2ME.ST :
* ENTERS INTO AGREEMENT WITH CURENC HOLDING AB TO ACQUIRE
COMPANY'S SUBSIDIARY CURENC AB AND THEREBY ALL OF ITS PATENTS,
PATENT APPLICATIONS AND THE RIGHT TO FUTURE INTELLECTUALS ASSETS
* PAYMENT TO BE MADE THROUGH DIRECTED SET-OFF ISSUE OF
266,666
B-SHARES IN S2MEDICAL
* ISSUE PRICE WILL CORRESPOND TO CLOSING PRICE ON THE DAY OF
THE
ISSUE
* CURENC HOLDING AB HAS ALSO THE RIGHT TO 1.5% ROYALTY BASED
ON
SALE OF PRODUCTS AND SERVICES RELATED TO ACQUISITION BETWEEN
2021-2027, PROVIDED THAT THIS EXCEEDS SEK 50 MILLION PER YEAR
AND AS LONG AS CURENC HOLDING AB OWNS AT LEAST 100,000 SHARES IN
S2MEDICAL
Source text for Eikon: ID:nWkr23MhcZ
Further company coverage: S2ME.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))